Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 72.39
+0.18 (0.25%)
At close: Feb 13, 2026
Xiamen Amoytop Biotech Revenue
In the year 2025, Xiamen Amoytop Biotech had annual revenue of 3.70B CNY with 31.18% growth. Xiamen Amoytop Biotech had revenue of 1.22B in the quarter ending December 31, 2025, with 40.99% growth.
Revenue
3.70B
Revenue Growth
+31.18%
P/S Ratio
8.00
Revenue / Employee
1.53M
Employees
2,685
Market Cap
29.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.70B | 878.41M | 31.18% |
| Dec 31, 2024 | 2.82B | 716.84M | 34.13% |
| Dec 31, 2023 | 2.10B | 573.42M | 37.55% |
| Dec 31, 2022 | 1.53B | 394.68M | 34.86% |
| Dec 31, 2021 | 1.13B | 338.29M | 42.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition